Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fluvastatin-induced dermatomyositis].

N Thual1, K Penven, J-M Chevallier

  • 1Service de Dermatologie, Centre Hospitalier Universitaire de Caen.

Annales De Dermatologie Et De Venereologie
|February 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of the sentinel lymph node procedure following the approval of adjuvant anti-PD-1 therapy for stage IIB and IIC melanoma: A multicenter study from RICMEL database.

Annales de dermatologie et de venereologie·2026
Same author

Atypical eosinophilic pustular folliculitis successfully treated with mepolizumab.

Annales de dermatologie et de venereologie·2025
Same author

Theragnostic approach of venous malformations in 2025: Similarities and differences with oncology advances.

Presse medicale (Paris, France : 1983)·2025
Same author

Hyperglycemic hyperosmolar coma induced by alpelisib in PIK3CA-related overgrowth spectrum (PROS).

Annales de dermatologie et de venereologie·2025
Same author

Efficacy, tolerance and acceptability of pulsed dye laser on facial and neckline telangiectasias in systemic scleroderma: a prospective open-label monocentric study in 21 patients.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology·2024
Same author

Idiopathic facial aseptic granuloma in children: Management and long-term follow-up.

Annales de dermatologie et de venereologie·2023
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

This case report details a rare instance of drug-induced dermatomyositis linked to fluvastatin. The patient

Area of Science:

  • Dermatology
  • Rheumatology
  • Pharmacology

Background:

  • Dermatomyositis is a rare inflammatory condition with few documented iatrogenic causes.
  • Drug-induced dermatomyositis is uncommon, with statins previously implicated in a limited number of cases.

Observation:

  • A 76-year-old male developed a rash and muscle weakness after starting fluvastatin for dyslipidemia.
  • Elevated creatine phosphokinase (CPK) levels and muscle biopsy confirmed dermatomyositis.
  • Neoplasia and autoimmune diseases were ruled out.

Findings:

  • The patient's symptoms resolved spontaneously within one month of discontinuing fluvastatin, without corticosteroid treatment.
  • This is the first reported case of dermatomyositis associated with fluvastatin, a HMG-CoA reductase inhibitor.

Related Experiment Videos

  • It is also only the second reported case of drug-induced dermatomyositis resolving solely after drug withdrawal.

    • Implications:

    • Clinicians should consider fluvastatin as a potential cause of dermatomyositis, especially in patients with unexplained muscle weakness and rash.
    • Routine investigation for iatrogenic causes, including statin use, is crucial in diagnosing dermatomyositis.
    • The spontaneous resolution highlights the importance of medication review in managing inflammatory dermatoses.